-+ 0.00%
-+ 0.00%
-+ 0.00%

Belite Bio Q4 EPS $(0.70) Misses $(0.54) Estimate

Benzinga·03/02/2026 11:16:27
Listen to the news
Belite Bio (NASDAQ:BLTE) reported quarterly losses of $(0.70) per share which missed the analyst consensus estimate of $(0.54) by 29.15 percent. This is a 118.75 percent decrease over losses of $(0.32) per share from the same period last year.